Indication

Osteomyelitis

Osteomyelitis is an acute or chronic infection of the bone and marrow tissue, primarily affecting the skeletal system across pediatric and adult populations. Read more about Osteomyelitis

16 drugs 14 manufacturers

Advertisement

Drugs that treat it

Common Osteomyelitis therapies.

Showing 1–9 of 16 drugs

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
SAGENT PHARMACE
Filter & compare in the drug finder →Opens the drug finder with Osteomyelitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Osteomyelitis.

Osteomyelitis is an acute or chronic infection of the bone and marrow tissue, primarily affecting the skeletal system across pediatric and adult populations.

It most commonly arises from pyogenic bacteria, particularly *Staphylococcus aureus*, through hematogenous seeding, contiguous spread from adjacent soft-tissue infections, or direct inoculation following open fractures or orthopedic surgical procedures.

Pathophysiologically, the condition is defined by progressive vascular compromise, local inflammatory bone destruction, and ischemia, which frequently leads to bone necrosis with the formation of devitalized bone fragments and chronic fistulae or soft-tissue abscesses if untreated.

Clinically, affected patients present with localized bone pain, tenderness, erythema, warmth, and systemic signs such as fever and malaise.

Personalize your experience

Follow Osteomyelitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it